Deutsche Bank
PVLA

Deutsche Bank’s Palvella Therapeutics PVLA Stock Holding History

Deutsche Bank’s Portfolio PVLA Stock Details PVLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.81M Buy
11,838
+4,054
+52% +$492K ﹤0.01% 1965
2026
Q1 		$970K Buy
7,784
+1,190
+18% +$124K ﹤0.01% 2195
2025
Q4 		$690K Buy
6,594
+528
+9% +$45K ﹤0.01% 2391
2025
Q3 		$380K Hold
6,066
– – ﹤0.01% 2692
2025
Q2 		$137K Buy
+6,066
New +$142K ﹤0.01% 3136
2021
Q3 		– Sell
-291
Closed -$89K – 4721
2021
Q2 		$89K Sell
291
-904
-76% -$198K ﹤0.01% 4179
2021
Q1 		$246K Sell
1,195
-125
-9% -$27.3K ﹤0.01% 3521
2020
Q4 		$264K Buy
1,320
+26
+2% +$5.41K ﹤0.01% 3312
2020
Q3 		$214K Buy
1,294
+445
+52% +$101K ﹤0.01% 3177
2020
Q2 		$211K Buy
849
+105
+14% +$24.6K ﹤0.01% 3118
2020
Q1 		$135K Sell
744
-790
-51% -$199K ﹤0.01% 3131
2019
Q4 		$443K Buy
1,534
+1,338
+683% +$371K ﹤0.01% 2784
2019
Q3 		$52K Sell
196
-272
-58% -$105K ﹤0.01% 3915
2019
Q2 		$175K Sell
468
-495
-51% -$148K ﹤0.01% 3904
2019
Q1 		$257K Sell
963
-1,415
-60% -$336K ﹤0.01% 3863
2018
Q4 		$505K Buy
2,378
+530
+29% +$164K ﹤0.01% 3320
2018
Q3 		$828K Buy
1,848
+469
+34% +$204K ﹤0.01% 3468
2018
Q2 		$559K Sell
1,379
-1,025
-43% -$488K ﹤0.01% 3789
2018
Q1 		$1.31M Buy
2,404
+234
+11% +$145K ﹤0.01% 3148
2017
Q4 		$1.31M Buy
2,170
+1,386
+177% +$644K ﹤0.01% 3015
2017
Q3 		$359K Buy
784
+291
+59% +$124K ﹤0.01% 3585
2017
Q2 		$198K Sell
493
-324
-40% -$94.7K ﹤0.01% 3927
2017
Q1 		$169K Buy
+817
New +$145K ﹤0.01% 3681
2016
Q4 		– Sell
-433
Closed -$63K – 5102
2016
Q3 		$63K Buy
+433
New +$57.5K ﹤0.01% 4117

Other funds holding PVLA

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
FCM
Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return

Deutsche Bank's PVLA Position: Q2 2026 in Review

Deutsche Bank increased its Palvella Therapeutics (PVLA) stake by 52% in Q2 2026, buying an estimated $492K and bringing the position to 11,838 shares worth $1.81M. The position accounts for ﹤0.01% of the portfolio, ranked #1965.

Deutsche Bank first reported a position in PVLA in Q3 2016 and has held it in 24 quarters since. 197 funds tracked by Wall St. Rank hold PVLA as of Q2 2026.

  • Deutsche Bank held 11,838 shares of Palvella Therapeutics worth $1.81M as of Q2 2026.
  • Deutsche Bank bought 4,054 Palvella Therapeutics shares in Q2 2026, an estimated $492K.
  • Palvella Therapeutics made up ﹤0.01% of Deutsche Bank's portfolio in Q2 2026, its #1965 holding.
  • Deutsche Bank first reported a position in Palvella Therapeutics in Q3 2016 and has held it in 24 quarters since.
  • 197 funds tracked by Wall St. Rank held Palvella Therapeutics as of Q2 2026.

Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.